A new classification approach for comparing two active treatments when there is no prior projection on which one is better-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A new classification approach for comparing two active treatments when there is no prior projection on which one is better

Published:2011-11-15 Issue:30 Volume:30 Page:3488-3495
ISSN:0277-6715
Container-title:Statistics in Medicine
language:en
Short-container-title:Statist. Med.

Author:

Qu Yongming¹,Liu Rong¹,Dmitrienko Alexei¹,Offen Walter¹

Affiliation:

1. Department of Global Statistical Science; Eli Lilly and Company; Indianapolis IN USA

Publisher

Wiley

Subject

Statistics and Probability,Epidemiology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/sim.4402/fullpdf

Reference11 articles.

1. International Conference on Harmonization Choice of Control Group and Related Design and Conduct Issues in Clinical Trials 2000

2. Multiple Testing Problems in Pharmaceutical Statistics

3. Hypothesis testing in clinical trials;Green;Hematology/Oncology Clinics of North America,2000

4. International Conference on Harmonisation: General Considerations for Clinical Trials (ICH E-8), 1997

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Insulin lispro 25/75 and insulin lispro 50/50 as starter insulin in Japanese patients with type 2 diabetes: subanalysis of the CLASSIFY randomized trial;Endocrine Journal;2017

2. Comparison of insulin lispro mix 25 with insulin lispro mix 50 as insulin starter in Chinese patients with type 2 diabetes mellitus (CLASSIFY study): Subgroup analysis of a Phase 4 open-label randomized trial;Journal of Diabetes;2016-09-26

3. Comparison of insulin lispro mix 25 with insulin lispro mix 50 as an insulin starter in Asian patients with type 2 diabetes: a phase 4, open-label, randomized trial (CLASSIFY study);Diabetes/Metabolism Research and Reviews;2016-06-14

4. Extending the classification approach for comparing two active treatment arms to binary and time-to-event outcomes;Journal of Biopharmaceutical Statistics;2016-06-10

5. Effect of Total Daily Dose on Efficacy, Dosing, and Safety of 2 Dose Titration Regimens of Human Regular U-500 Insulin in Severely Insulin-Resistant Patients with Type 2 Diabetes;Endocrine Practice;2016-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3